Russell Investments Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60
| Closed | -$2.04K | – | 3861 |
|
|
2025
Q1 | $2.04K | Buy |
60
+10
| +20% | +$340 | ﹤0.01% | 3516 |
|
|
2024
Q4 | $1.97K | Hold |
50
| – | – | ﹤0.01% | 3447 |
|
|
2024
Q3 | $2.35K | Sell |
50
-200
| -80% | -$9.4K | ﹤0.01% | 3352 |
|
|
2024
Q2 | $13.5K | Buy |
+250
| New | +$13.5K | ﹤0.01% | 3016 |
|
|
2023
Q4 | – | Sell |
-1,590
| Closed | -$72.7K | – | 3226 |
|
|
2023
Q3 | $72.7K | Hold |
1,590
| – | – | ﹤0.01% | 2689 |
|
|
2023
Q2 | $90.7K | Buy |
1,590
+1,578
| +13,150% | +$90K | ﹤0.01% | 2625 |
|
|
2023
Q1 | $543 | Buy |
+12
| New | +$543 | ﹤0.01% | 3106 |
|
|
2022
Q2 | – | Sell |
-1,576
| Closed | -$98K | – | 2898 |
|
|
2022
Q1 | $98K | Sell |
1,576
-424
| -21% | -$26.4K | ﹤0.01% | 2566 |
|
|
2021
Q4 | $151K | Sell |
2,000
-1,900
| -49% | -$143K | ﹤0.01% | 2772 |
|
|
2021
Q3 | $436K | Buy |
+3,900
| New | +$436K | ﹤0.01% | 2523 |
|
|
2020
Q4 | – | Sell |
-633
| Closed | -$53K | – | 3064 |
|
|
2020
Q3 | $53K | Sell |
633
-875
| -58% | -$73.3K | ﹤0.01% | 3070 |
|
|
2020
Q2 | $113K | Sell |
1,508
-5,349
| -78% | -$401K | ﹤0.01% | 2860 |
|
|
2020
Q1 | $293K | Buy |
+6,857
| New | +$293K | ﹤0.01% | 2409 |
|
|
2018
Q1 | – | Sell |
-101,188
| Closed | -$2.15M | – | 2920 |
|
|
2017
Q4 | $2.15M | Buy |
+101,188
| New | +$2.15M | ﹤0.01% | 1779 |
|